Category: What’s News Asia

HONG KONG SAR – Media OutReach Newswire – 26 August 2026 – Milkground (600882.SH), one of China’s leading cheese brands, today announced a strategic partnership with DKSH, a leading partner for companies seeking to grow their consumer goods business in Asia and beyond, to bring a wide range of cheese products to consumers in Hong Kong. The partnership was unveiled at a press conference attended by Milkground President Kuai Yulong and DKSH Vice President, FMCG, Greater China, Hugo Reyes, along with senior executives from both companies.

With over 160 years of experience helping companies grow across Asia and beyond, DKSH is headquartered in Switzerland and operates in 35 markets, working with more than 500 consumer goods companies and 4,800 business partners to connect them to extensive retail and food services networks across the region.

Hugo Reyes, DKSH Vice President, FMCG, Greater China, said: “Milkground has built a reputation in China for quality, nutrition, and innovation that few dairy brands can match. Consumer habits across Asia are shifting toward convenient and healthy snacking, trusted premium brands and family-oriented food solutions – trends that open up substantial opportunities for Milkground’s full range across multiple markets.”

The partnership will begin in Hong Kong’s retail market, with plans to expand into food services and, over time, other markets across Asia through DKSH’s regional network. For Milkground, DKSH was a natural choice: entering a new market takes more than getting products onto shelves – it takes an understanding of local tastes, strong retail relationships, and the patience to build a brand families trust over time, all strengths DKSH brings to the table.

Reyes added that Milkground, backed by Mengniu Group, brings mature industry experience, strong dairy R&D capabilities, and a solid supply chain, giving it a firm base for future category growth. As dairy consumption grows across Asia, he said the two companies see room to expand beyond cheese over time and look forward to exploring that opportunity together.

Kuai Yulong, Milkground President, said: “Hong Kong’s energy and openness to the world made it the natural place to start. Hong Kong remains one of Asia’s most dynamic and internationally connected consumer markets. For Milkground, our ambition is to become not just a leading Chinese brand, but a name recognised all over the world. Today’s launch is the first step of that journey.”

Looking ahead, Milkground outlined three priorities for its partnership with DKSH in Hong Kong:

Growing the range: From children to adults, from everyday snacking to the family table, Milkground plans to keep expanding and refining its cheese offerings, so Hong Kong consumers have more ways to enjoy quality cheese – and more households across the city can make it part of daily life.

Listening to the market: Milkground will pay close attention to how Hong Kong shoppers actually buy and use cheese. That feedback will keep shaping everything, from product updates and shelf displays to the in-store experience.

Working hand in hand with DKSH: Both companies plan to work closely, share information openly, and move quickly as they keep improving products, operations, and service together. The aim: happier retail partners and consumers, and a Milkground brand that Hong Kong trusts.

Kuai noted that Hong Kong consumers already have a strong appetite for cheese and well-established habits around it, which makes the city an easier market to enter than most. He sees it as the perfect place to test whether Milkground’s products can win over consumers used to international standards, calling it a meaningful proving ground for the brand’s broader ambitions.

Hong Kong is also central to Milkground’s plans beyond the city. Kuai Yulong outlined the company’s three-pronged roadmap for international expansion: first, use Hong Kong as the core to establish a presence across Hong Kong, Macau, Central Asia and Mongolia; second, expand into Southeast Asia, represented by Thailand, Malaysia and Singapore; and third, enter the Middle East, anchored by Saudi Arabia. To date, Milkground has already established a presence in Thailand, Singapore, Vietnam and Mongolia, and has reached a partnership agreement with a leading dairy company in Saudi Arabia.

Kuai further emphasised that overseas business is one of the wings under Mengniu Group’s “One Body, Two Wings” strategy. The group’s increasingly mature and systematic approach to overseas markets will help Mengniu’s international operations scale quickly, while leveraging its core strengths to accelerate global expansion.

Hashtag: #Milkground #DKSH

The issuer is solely responsible for the content of this announcement.

About Milkground

Milkground (Stock Code: 600882.SH) is the only A-share listed company in China focused on cheese. Controlled by Mengniu under COFCO, the company operates as a dual-brand cheese platform running both the Milkground and Mengniu Cheese brands. Headquartered in Shanghai, it operates six factories in Fengxian and Jinshan (Shanghai), Tianjin, Hohhot, Changchun, and Jilin, making it one of the mainland’s largest cheese producers.

With a global vision, Milkground has assembled an R&D team led by international experts. Backed by Mengniu Group, the company has established a Global Cheese R&D Innovation Center, and introduced world-class production equipment. The company collaborates with cheese makers from Europe and Australia to adopt advanced technologies. Using premium global ingredients and strict quality control across every step, it drives innovation throughout the supply chain to craft each cheese product with care.

Milkground’s product range includes Ready-to-Eat Nutrition, Family Cheese, and Foodservice & Industrial series. Its Cheese Sticks and Mozzarella, and Cheese Slices have become best-selling fan favorites.

Guided by a consumer-centered philosophy and craftsmanship in pursuit of excellence, Milkground is committed to making quality cheese a part of every household.

Website: https://www.milkground.cn/

About DKSH Group

For more than 160 years, DKSH has been delivering growth for companies in Asia Pacific, Europe, and North America across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, e-commerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 35 markets with 26,840 specialists, generating net sales of CHF 11.1 billion in 2025.

DKSH Business Unit Consumer Goods focuses on fast moving consumer goods, luxury and lifestyle products, food services, as well as beauty and wellness. With 13,620 specialists, the Business Unit generated net sales of CHF 3.4 billion in 2025. www.dksh.com

Hong Kong SAR – Media OutReach Newswire – 26 August 2026 – MicroBit Capital Management Limited (“MicroBit”), a Hong Kong-based investment manager specialising in virtual assets and frontier technologies, today announced the listing of the MicroBit Bitcoin and Gold Value ETF (HKD Counter: 3002.HK; USD Counter: 9002.HK) on The Stock Exchange of Hong Kong Limited (“HKEX”).

The ETF is Hong Kong’s first to offer exposure to both bitcoin and gold, offering a diversified approach across two value asset classes.

The Fund combines bitcoin’s long-term digital-asset potential with gold’s role as a store of value, offering diversified exposure in a single ETF. Gold may help stabilize overall portfolio volatility. The ETF also supports in-kind subscriptions and redemptions in bitcoin, while in-kind bitcoin subscriptions and redemptions provide eligible market participants with added flexibility.

Wilson Fung, Chief Executive Officer of MicroBit Group, said: ” We are proud to launch Hong Kong’s first Bitcoin and Gold ETF. By combining bitcoin’s digital-asset potential with gold’s established role as a store of value, the Fund offers investors a forward-looking, diversified allocation tool. This launch marks an important milestone in MicroBit’s mission to bridge traditional finance and the Web3 ecosystem.”

MicroBit will continue to explore innovative investment solutions and is committed to providing investors with a broader range of innovative and diversified investment tools.

Important Information:

Investment involves risks. Past performance does not represent future performance. The price of the fund may go up or down. Investors may suffer all or significant investment losses. Investors should not make any investment decisions solely based on this information. Please note that the investment risks listed below are not exhaustive. Investors should carefully read the prospectus, product key factsheet and relevant documents before making any investment decisions to understand details including product characteristics, risk factors and distribution policies, and seek for independent financial advice when necessary.

MicroBit Bitcoin & Gold Value ETF (the “Sub-Fund”) is a sub-fund of MicroBit Funds Series (Hong Kong) ETF OFC (the “Company”). The investment objective of the Sub-Fund is to seek long-term capital appreciation by providing diversified exposure to both digital and traditional store-of-value assets, namely bitcoin and gold. There can be no assurance that the Sub-Fund will achieve its investment objective.

MicroBit Bitcoin & Gold Value ETF could be subject to certain key risks such as Investment risk; Active investment management risk; Risks relating to bitcoin (including Bitcoin and bitcoin industry risk, Speculative nature risk, Extremely high volatility risk, Unforeseeable risk, Acceptance of bitcoin, Concentration of ownership risk, Fraud, market manipulation and security failure risk, Cybersecurity risks, Potential manipulation of Bitcoin Network risk, Regulatory risk, Internet risk, Fork risk, Virtual Assets’ trading platform risk in general and contagion risk, Risk of illicit use, Environment and energy consumption risk, Political or economic crisis risk, etc.); Gold market risk; Futures contracts risks; Bitcoin and gold concentration risk; New product risk; Risks in relation to Virtual Asset Trading Platform(s); Custody risk; Differences in dealing arrangements between Listed and Unlisted Classes of Shares; Differences in cost mechanisms between Listed and Unlisted Classes of Shares risk; Trading risk; Trading hours differences risk; Reliance on market makers risk; Early termination risk; Multi-counter risk.

The above products have been authorized by the Securities and Futures Commission (“SFC”). Authorization by the SFC does not imply official recommendation. This material is for reference only and does not constitute an offer or suggestion of any transaction in any products.

This material is prepared by MicroBit Capital Management Limited and has not been reviewed by the SFC. If you are in any doubt about the content of this material, please refer to the prospectus, product key facts statement and other relevant documents for details, and seek for independent financial advice when necessary.

MicroBit does not guarantee the accuracy, timeliness, completeness, or reliability of the information provided. All materials are presented “as is”, without any warranties of any kind, whether express or implied, including but not limited to merchantability, fitness for a particular purpose, or non-infringement. Unless otherwise specified, some of the views and recommendations are compiled by MicroBit based on publicly available data and market experience.

Copyright © 2026 MicroBit Capital Management Limited. All rights reserved.
Hashtag: #MicroBit#Cryptocurrency#Gold#HongKong#ETF#Investment

https://www.microbit.ai/en/
https://www.linkedin.com/company/microbit-capital/?viewAsMember=true
https://x.com/microbitcapital?s=11
Wechat: 小飞资产MicroBit Capital

The issuer is solely responsible for the content of this announcement.

MicroBit Capital Management Limited

MicroBit Capital Management Limited is a premier Hong Kong-based investment manager specialising in thematic investing across virtual assets and frontier technologies. We are committed to delivering innovative investment solutions to institutional investors, family offices, high-net-worth individuals, and retail investors, empowering them to diversify portfolios and capture the transformative potential of virtual assets and frontier technologies.

MicroBit is licensed by the Securities and Futures Commission of Hong Kong (SFC) for Type 1 (Dealing in Securities), Type 4 (Advising on Securities) and Type 9 (Asset Management) regulated activities, and is subject to additional terms and conditions for Virtual Asset Fund Managers (VAFMs) imposed by the SFC (“VAFM T&Cs”). Welcome to visit our website for further details: https://www.microbit.ai/en/.

HONG KONG SAR – EQS Newswire – 26 August 2026 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its interim results for the six months ended 30 June 2026 (the “Period”).

Key Accomplishments in the First Half of 2026

During the Period, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include:

1. During the Period, the Group’s revenue reached approximately HK$273.8 million, with net profit standing at approximately HK$31.2 million. Cash generation remained solid, with operating cash flow at approximately HK$11.4 million. Despite temporary earnings compression resulting from regulatory adjustments and front-loaded investments in R&D, commercialization, and international expansion, the Group demonstrated operational resilience by remaining profitable and financially strong.

2. As at 30 June 2026, total equity increased by 8.6% to approximately HK$448.7 million, reflecting a strengthened capital base. The debt-to-equity ratio improved to 34.9%, demonstrating active deleveraging and prudent capital stewardship. The Group remains in a net cash positive position, with a cash ratio well above 1, indicating that cash and cash equivalents significantly exceed near-term liabilities. This strong liquidity cushion enables the Group to comfortably absorb the temporary reduction in net profit during the Period without compromising its financial stability. Together, these strengths position the Group to support future R&D investment, commercialization initiatives, and international expansion.

3. Revenue of Bogutai® increased significantly by 39.3% year-on-year (“YoY”), driven by the ongoing market development and engagement with this innovative osteoporosis therapy within the medical community and among patients in China. As of the first quarter of 2026, Bogutai® ranked second in overall market share and first in the retail channel among teriparatide products in China. Its nationwide sales surpassing those of the originator brand, achieving these market positions within approximately two years of commercial launch.

4. During the Period, the Group officially commenced the commercial launch and market promotion of its high-end series, GeneQueens®, further enriching its portfolio in functional skincare and post-procedure medical aesthetics. The premium line incorporates a proprietary triple-protein complex (Fibronectin, Type III Collagen, and Type XVII Collagen), each formatted at a high concentration of 1,000 ppm to optimize cellular repair and anti-aging performance. This milestone demonstrates concrete progress in accelerating the commercialization of its synthetic biology platform.

5. The Group is advancing the development of its BMP-2 regenerative medicine program. Utilizing its proprietary ECO-KSFA® platform, the Group has successfully established a high-yield production process for BMP-2 API, a crucial growth factor in regenerative medicine widely applied in spinal fusion and bone defect reconstruction. During the Period, the Group completed pilot-scale manufacturing process for the BMP-2 drug substance and initiated development of a sustained-release gel formulation, laying a solid foundation for finalizing the product’s clinical dosage form.

6. The next-generation generic antifungal drug, Isavuconazonium sulfate capsules, completed all supplementary studies required by the regulator and the Group is preparing to submit the corresponding documentation to the Center for Drug Evaluation (CDE) in the second half of 2026. To support future commercialization, the Group has commissioned a dedicated production line specifically designed for the product and established strategic partnerships with high-quality API suppliers to ensure reliable manufacturing capacity and supply for commercialization.

Interim Results

The first half of 2026 marked a strategic transition period for the Group, characterized by portfolio optimization alongside expanding channel and market access. Revenue during the Period was temporarily impacted by strategic volume-based procurement (VBP) pricing adjustments for Pinup® and, to a lesser extent, GeneTime®, coupled with the structural impact of latest biologics value-added tax (VAT) policies on net selling price. For the Period, the Group recorded revenue of approximately HK$273.8 million, representing a decrease of 11.7% YoY.

Revenue of Bogutai® increased significantly from approximately HK$65.6 million to approximately HK$91.4 million, representing an increase of 39.3%. Revenue of Boshutai® increased by 50.8% from approximately HK$6.1 million to approximately HK$9.2 million. GeneTime® recorded a decrease of 12.3% in revenue from approximately HK$107.8 million to approximately HK$94.5 million. Sales volume of GeneTime® achieved high-single-digit YoY growth, reflecting continued strong underlying demand and the initial benefits of broader hospital access and prescription-base expansion. GeneSoft® recorded a 1.6% YoY increase in revenue from approximately HK$18.5 million to approximately HK$18.8 million. Pinup® recorded a decrease of 47.1% in revenue from approximately HK$108.9 million to approximately HK$57.6 million. With a limited number of product portfolio and the ongoing optimization of its marketing and distribution teams, revenue from 肌顏態® increased from approximately HK$1.3 million to approximately HK$2.2 million, representing a 69.2% YoY growth. Revenue contribution from the Group’s newly launched medical device product 金因敷® and 金因康® (Diquafosol Sodium Eye Drops) were immaterial during the Period. The Group is expanding its digital and social media presence to raise 金因敷® brand awareness, while advancing targeted non-public channel expansion to accelerate 金因康® uptake.

Gross profit was approximately HK$222.7 million, representing a decrease of 12.4% as compared with approximately HK$254.1 million for the first half of 2025, whereas as gross profit margin remained stable at 81.3%. Profit for the Period decreased by 59.0% YoY to approximately HK$31.2 million. The decrease primarily reflected short-term profitability pressure during the Group’s strategic transformation, including lower absolute gross profit resulting from pricing adjustments for certain core products and the VAT-related pricing impact, together with continued investment in commercialization, new product launches, pipeline development, and international expansion. The earnings per share were approximately HK$0.52 cents, compared with HK$1.27 cents in the first half of 2025.

Prospects

Through targeted commercial and R&D investments in the first half of 2026, the Group enters the second half well positioned to accelerate its business transformation. As generic therapies continue to yield ground to higher-margin biopharmaceuticals within the Group’s portfolio, this evolving revenue mix is expected to deliver sustained margin expansion over the long term. With biopharmaceuticals recognized for the first time as an emerging pillar industry supported by the state, the Group is committed to growing its innovation capabilities and expanding its commercial reach to capture this growing market opportunity.

Mr. Kingsley Leung, Chairman of Uni-Bio Science, commented, “The first half of 2026 presented a challenging operating environment, which we view as a transitional period toward a more diversified and all-round range of product offerings and promotional channels. During the period, we made significant progress in strengthening both the breadth and depth of our commercial platform while advancing a robust pipeline of innovative therapies. Our omni-channel strategy, spanning public hospitals, an expanding distributor network, retail pharmacy locations, and leading e-commerce platforms, continues to broaden patient access across China, including deeper penetration into Tier-3 and Tier-4 cities. At the same time, we are executing a disciplined, product-specific commercialization approach, tailoring our strategies to the distinct market dynamics of each of our eight core products. Beyond our domestic base, we are accelerating our global ambitions. We are advancing Bogutai®’s international expansion, together with our ongoing U.S. FDA submission, an important step toward establishing our first overseas commercialized therapy.

Our pipeline continues to advance meaningfully, from our proprietary EGF/FGF compound gel for wound care to next-generation BFS-based GeneSoft® formulations and our BMP-2 regenerative therapy, all underpinned by our proprietary ECO-KSFA® synthetic biology and Biological Hydrogel technology platforms. These innovation engines position us to continue delivering differentiated, high-value therapies across pharmaceuticals, medical devices, and medical aesthetics. We remain confident that our integrated strategy, combining commercial excellence, global expansion, and platform-driven innovation, will create sustainable long-term value for our patients, partners, and shareholders.”

Hashtag: #Uni-BioScienceGroup

The issuer is solely responsible for the content of this announcement.

About Uni-Bio Science Group Limited

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2001 (Stock Code: 00690.HK). The Group is committed to powering the advancement of regenerative medicine with next-generation synthetic biology and complex peptide innovation. Focusing on four core research areas—muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration—the Group has built a diversified product pipeline encompassing innovative biologics, high-value generic drugs, and medical aesthetics. The Group operates GMP-compliant production bases in Beijing, Dongguan, and Shenzhen, with fully integrated capabilities spanning R&D, manufacturing, and commercial sales. Uni-Bio Science Group is dedicated to be the global leader in regenerative medicine, redefining how science restores and extends human life.

For further information, please contact: ir@uni-bioscience.com

HONG KONG SAR – Media OutReach Newswire – 26 August 2026 – Hosted by The Hong Kong Polytechnic University (PolyU) and title sponsored by Bank of China (Hong Kong) (BOCHK), the PolyU x BOCHK International Future Challenge (Hong Kong Regional Final) concluded earlier (24 August) at the Hong Kong Convention and Exhibition Centre. Featured on the main stage during the Global Unicorn Summit (the Summit), organised by the Hong Kong Ta Kung Wen Wei Media Group, 18 top Challenge startup teams, selected from over 300 entries, showcased their strengths competing for various awards and the top four spots which advance to the Grand Final. Prof. Jin-Guang TENG, PolyU President, meanwhile delivered a keynote speech at the Summit themed “How University Research Empowers Industrial Innovation”. He elaborated on the mission and characteristics of university research, and shared PolyU’s successful experience in driving research translation through the establishment of Mainland Translational Research Institutes.

Following its title sponsorship of the inaugural PolyU x BOCHK International Future Challenge Grand Final, BOCHK demonstrated its continued support this year as the title sponsor for both the Hong Kong Regional Final and the Grand Final of the PolyU International Future Challenge (PolyU IFC) 2026, joining hands with PolyU to nurture young innovation and technology (I&T) talents and drive high-quality development in the innovation and entrepreneurship ecosystem.

The Hong Kong Regional Final focused on five cutting-edge fields: Life Sciences and Healthcare, Advanced Manufacturing and Microelectronics, Digital Economy and Financial Technology, Smart City and Green Living, as well as Aerospace and Aviation Technology. The Hong Kong region competition generated an enthusiastic response, fully demonstrating Hong Kong’s vitality and appeal as an international I&T hub. The 18 shortlisted teams made on-site pitches and exhibited at the exhibition zone of the Summit, presenting their innovations to visitors, investors, and industry leaders.

Prof. Zijian ZHENG, PolyU Vice President (Knowledge Transfer), remarked, “With Hong Kong serving as a super-connector, PolyU IFC 2026 successfully builds a cross-regional platform that closely connects the Chinese Mainland, the Middle East and beyond, creating unprecedented opportunities for global innovation and collaboration. We are delighted to see 18 outstanding startup teams showcase their innovative solutions. These projects are a testament to the vision, perseverance and collaborative spirit that define the PolyU mission as an innovative world-class university. PolyU’s unique startup ecosystem, PolyVentures, boasts over 900 active startups, including unicorns and listed companies. We look forward to today’s teams leveraging this platform to step onto a broader entrepreneurial stage.”

The Hon Ken LEE, Advisor to BOCHK and Legislative Council Member, stated in the speech, “BOCHK is pleased to once again support PolyU’s flagship innovation competition, joining hands to build a supportive ecosystem that nurtures innovation and technology talent. By accelerating the practical application of innovative ideas and research achievements, this initiative aligns closely with national strategies and HKSAR Government policies, supporting Hong Kong’s development into an international innovation and technology hub.”

Prof. Christopher CHAO, PolyU Senior Vice President (Research and Innovation), Prof. Cheng DONG, PolyU Associate Vice President (Knowledge Transfer) and Mr Marston WONG, Deputy General Manager of Commercial Banking Departmentof BOCHK presented the top four awards. Following rigorous evaluation by the judging panel and on-site voting, 11 winning teams were selected. The top four teams from the Hong Kong Regional Final advance to the Grand Final held in Hong Kong in January next year, to compete with winners from other regions for the highest honours.

The winning teams from the Hong Kong Regional Final are as follows:

As the University’s flagship innovation and entrepreneurship competition, PolyU IFC is strategically aligned with the Nation’s 15th Five-Year Plan and “Artificial Intelligence (AI)+” initiative. This year, an overseas region was introduced for the first time, meaning the inclusion of nine competition regions in total: Hong Kong, Qianhai, Wuhan, Nanjing, Jinjiang, Hefei, Hangzhou, Wuxi and Saudi Arabia. Leveraging the crossborder network of the PolyU Mainland Translational Research Institutes and in collaboration with local government authorities and leading enterprises, the Challenge focuses on “AI+” to foster precise alignment between research projects and regional industrial resources.

To date, over 1,400 competition applications have been received from across the nine competition regions. Registration for the Jinjiang, Hefei, Hangzhou and Wuxi regions is currently open. For further details, please visit the official PolyU IFC website.

Hashtag: #PolyU #BOCHK #GlobalUnicornSummit

https://www.polyu.edu.hk

The issuer is solely responsible for the content of this announcement.

SINGAPORE – Media OutReach Newswire – 26 August 2026 – Homegrown consumer technology brand PRISM+ is leveraging Shopee to bring its growing range of smart home solutions to more consumers, as it expands beyond the monitors and televisions it first built its name on. Founded in 2017 after identifying a gap for high-quality yet affordable consumer technology, the brand now offers products spanning air conditioners, smart locks, vacuum cleaners, ceiling fans, refrigerators, air purifiers and laundry appliances, with a focus on addressing evolving consumer needs.

As the business expands into new categories, reaching new consumers and building understanding around unfamiliar products have become increasingly important. Since joining Shopee in 2023, the platform has become a major e-commerce channel, giving the brand new ways to engage consumers as its smart home business grows.

Bringing New Products to New Audiences

While its own website continues to serve loyal customers already familiar with the brand, the brand has found that Shopee connects it with different audiences, particularly older shoppers and families discovering its products for the first time.

“Our own channels have always been central to how we build relationships with customers. Shopee extends that reach, putting PRISM+ in front of mature shoppers and families discovering the brand for the first time, and giving us an efficient way to grow those audiences alongside our own platforms,” said Jonathan Wong, CEO of PRISM+.

Meanwhile, its experience centres and retail stores complement this online reach by increasingly serving as where consumers can experience products in person. Through Shopee Live, the brand can extend this consultative experience online, where livestreamers can walk shoppers through the products in real time.

Helping Consumers Understand New Ideas

For newer product concepts, reaching consumers is only the first step. The brand also needs to help them understand why they might need a product, how it fits into their lives, and answer questions that may otherwise hold back a purchase.

As many of its appliances are too large to easily seed to creators, livestreamers can instead bring the showroom experience online from its retail stores. This gives consumers the product demonstrations and immediate answers they may need for higher-value purchases, from whether a product suits their needs to practical details such as delivery fees, giving them greater confidence to complete their purchase online.

This is particularly important as the brand introduces products that consumers may not already know to look for. Its compact mini washer-dryer is one example. Some consumers initially questioned why they would need another washing machine, so content was used to showcase how having the product completely eliminated hand-washing from laundry routines by allowing homeowners to separate smaller loads such as baby clothes, kitchen rags, and undergarments, helping the brand build understanding and interest around a new product category.

“Innovation isn’t only about responding to what consumers are already searching for. Sometimes it’s about introducing new solutions to existing pain points that haven’t been considered before. Shopee Live allows us to explain those ideas, answer questions immediately and help customers understand the value behind new categories,” Wong added.

Supporting a Growing Smart Home Business

As awareness and demand grow alongside its expanding smart home range, the brand also uses Shopee’s wider seller tools to strengthen product visibility, drive sales and support the customer experience beyond purchase.

Shopee Ads are a key part of this approach, allowing the brand to reach more shoppers while giving it greater control over the exposure of products it wants to promote.

“As we introduce more products, not every consumer will already know what to look for. Being able to focus our marketing on different products helps us introduce more of our range to the right audiences,” Wong said.

Campaigns and vouchers further support the brand’s efforts to attract shoppers and drive purchases, with a significant share of its Shopee sales taking place during campaign periods. It has also found that timing and campaign mechanics matter, with a well-executed weekend campaign sometimes performing better than a mega campaign held on a weekday.

The experience does not end at checkout. PRISM+ also joined Fulfilled by Shopee (FBS) this year, which covers its products that do not require installation. For eligible products such as monitors and air purifiers, shoppers can opt for Same Day Delivery to have their orders delivered on the day of purchase, giving them faster delivery for more immediate needs while retaining the convenience of shopping online.

Looking ahead, PRISM+ plans to continue expanding its smart home portfolio and reaching more consumers through Shopee. Beyond Singapore, the brand is already on ShopeeMall in Malaysia, and building its presence in the Philippines, as it brings more of its smart home solutions to consumers across the region. Earlier this year, the brand was shortlisted to participate in Malaysia’s first-ever Shopee Hyper Brand Day with physical pop-ups at AEON Mall Tebrau City, Johor, as well as livestreams with popular affiliates like Sam Lim.

Hashtag: #Shopee

The issuer is solely responsible for the content of this announcement.

About Shopee

Shopee is the largest e-commerce platform in Southeast Asia and Taiwan, and is a leading e-commerce platform in Brazil. Shopee promotes an inclusive and sustainable digital ecosystem by enabling businesses to digitalise and grow their online presence, helping more people access and benefit from digital services, and uplifting local communities.

Shopee offers an easy, secure, and engaging experience that is enjoyed by millions of people daily. Shopee is also a key contributor to the digital economy, with a firm commitment to helping homegrown brands and entrepreneurs succeed in e-commerce.

Shopee is part of Sea Limited (NYSE: SE), a global technology company. Sea’s mission is to better the lives of consumers and small businesses with technology through its three core businesses: Shopee, Garena, and Monee.

Program to evaluate a cleaner, lower-cost and scalable pathway for converting premium Canadian graphite into finished battery-grade anode material in North America

Highlights

• Mine-to-Anode Platform: Focus and C4V have signed a non-binding Memorandum of Understanding to evaluate an integrated pathway by combining Lac Knife’s high-purity graphite concentrate with C4V’s Green Anode Technology.
• Premium High-Purity Feedstock: C4V’s Green Anode Technology requires natural graphite concentrate of approximately 98% carbon, a demanding feedstock specification that Lac Knife has demonstrated the ability to meet through conventional flotation.
• Commercialization Potential: Successful technical validation would establish the foundation for definitive commercial agreements involving technology licensing, downstream manufacturing, customer qualification, strategic partnerships and potential offtake opportunities.
• Advanced Materials Strategy: The collaboration supports Focus’s broader strategy to expand beyond resource development into downstream processing, advanced materials and higher-value segments of the North American supply chain.
• Strengthening Allied Supply Chains: The collaboration combines Canadian graphite resources with American processing technology to support a secure, scalable and more resilient North American battery materials supply chain.

Ottawa, Ontario–(Newsfile Corp. – August 26, 2026) – Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) (“Focus” or the “Company“), a Canadian developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence and industrial applications, is pleased to announce that it has entered into a non-binding Memorandum of Understanding (“MOU“) with Charge CCCV LLC (“C4V“), a U.S.-based battery technology company, to evaluate graphite concentrate from Focus’s 100%-owned Lac Knife Project (“Lac Knife” or the “Project“) in Quebec using C4V’s proprietary automated Green Anode Technology (“Green Anode Technology” or the “Technology“).

A North American Mine-to-Anode Platform

C4V’s Green Anode Technology is designed to convert premium natural graphite concentrate directly into finished coated spherical purified graphite (“cSPG“) through a highly automated process designed to reduce water and energy consumption, chemical usage and overall process complexity. Compared with conventional processing routes involving multiple upgrading and purification stages, the Technology is intended to provide a cleaner, more efficient pathway from graphite concentrate to finished battery-grade anode material. C4V has successfully demonstrated the Technology at pilot scale.

C4V’s broader anode-development experience includes a multi-year program focused on developing high-performance active anode materials using high-purity natural graphite feedstock. The technology has demonstrated successful development and qualification pathways for active anode material and previously supported a binding offtake agreement with a globally recognized U.S. electric vehicle (“EV“) and battery energy storage manufacturer (“BESS“) for U.S.-produced active anode material, subject to specified development, production and customer-qualification conditions. The commercial pathway ultimately did not proceed as contemplated for reasons unrelated to the technical performance of the underlying anode technology. Focus was not a party to that arrangement.

C4V’s Green Anode Technology requires a high-purity natural graphite concentrate of approximately 98% carbon, a demanding feedstock specification that Lac Knife has demonstrated the ability to meet through conventional flotation alone. Lac Knife’s ability to produce high-purity flotation concentrate has been established through the Company’s 2023 NI 43-101 Feasibility Study¹ and further validated by its recent 8-tonne pilot-scale program², announced July 28, 2026, which produced concentrate grading up to 98.7% carbon through mechanical processing, without chemical or thermal purification.

Lac Knife is one of North America’s highest-grade feasibility-stage graphite deposits. The ability to begin downstream processing with a premium, high-purity concentrate has the potential to reduce processing requirements, reagent and energy consumption, shorten processing times and improve overall manufacturing efficiency. Combined with Lac Knife’s favourable purification characteristics, this provides a strong starting point for evaluating a cleaner, more efficient and potentially lower-cost pathway to finished anode material.

Under the MOU, the parties intend to complete an evaluation Program (the “Program“) to assess the technical and commercial suitability of Lac Knife graphite for processing through C4V’s Green Anode Technology. The Program will examine processing performance, product consistency and electrochemical characteristics and evaluate whether Lac Knife’s feedstock advantages can translate into a cleaner, more efficient and commercially competitive pathway from mine to finished battery-grade anode material, supporting future customer qualification, downstream product development and potential commercialization opportunities.

Richard Pearce, P.E., Technical Advisor to Focus Graphite, commented, “The success of any anode manufacturing process begins with the quality of the graphite feedstock. Higher-purity concentrate has the potential to reduce downstream processing requirements, improve manufacturing efficiency and enhance overall product consistency. Lac Knife has demonstrated exceptional concentrate quality through conventional flotation, making it an outstanding candidate for evaluation within C4V’s Green Anode Technology.”

“For years the anode has been the weakest link in the battery supply chain, dependent on foreign processing and heavy chemistry to reach purity,” said Dr. Shailesh Upreti, Chief Executive Officer of C4V. “Our Green Anode Technology was built to change that. C4V successfully demonstrated the technology through an earlier natural-graphite development program that advanced through customer qualification and ultimately supported a commercial agreement with a prominent U.S. EV and BESS manufacturer. We are excited to build on that technical foundation with Lac Knife’s exceptional graphite concentrate and evaluate a cleaner, more efficient and scalable North American pathway to finished battery-ready anode material.”

“North America is moving quickly to secure critical mineral supply chains from raw materials through advanced manufacturing,” said Dean Hanisch, Chief Executive Officer of Focus Graphite. “C4V’s previous work has demonstrated the commercial interest that can emerge when high-quality natural graphite is successfully advanced into finished anode material. For Focus, the opportunity is to demonstrate that potential with Lac Knife. If successfully validated, this platform could position us for customer qualification, strategic partnerships and potential offtake while helping build a more secure and competitive North American anode supply chain.”

Building a Higher-Value Graphite Platform

Beyond battery anode production, the collaboration also supports Focus’s objective of maximizing value across the graphite processing chain. Graphite fines and other material streams generated during anode production may be evaluated as conductive additives for lithium iron phosphate (“LFP“) batteries. Previous testing by Focus and C4V demonstrated that conductive additive material produced from Lac Knife graphite improved LFP cathode electrode density relative to baseline materials, highlighting an additional opportunity to improve resource utilization and support the Company’s broader zero-waste development strategy.

While the Green Anode Technology evaluation is focused on battery anode materials, it represents one component of Focus’s broader advanced materials strategy. In parallel, the Company is advancing a chemical-free electrothermal graphite purification process intended to produce ultra-high-purity graphite for battery, defence, nuclear, aerospace, energy storage and other advanced industrial applications. This effort is being advanced through the Company’s up to $14.1 million non-repayable funding agreement under Natural Resources Canada’s (“NRCan“) Global Partnerships Initiative (“GPI“).

If successful, the Program could demonstrate a differentiated Mine-to-Anode pathway that aligns with Canada’s “Mine-to-Market” critical minerals strategy by converting premium Canadian graphite into finished battery-grade anode material through a cleaner, lower-cost and scalable North American production process. The collaboration reflects Focus’s strategy of evolving from a graphite developer into an integrated advanced materials company participating across the battery value chain.

Subject to successful technical validation and the execution of definitive agreements, the Program could provide a foundation for expanded commercial collaboration, including technology licensing, downstream manufacturing, customer qualification, strategic partnerships and potential long-term offtake arrangements. The MOU is non-binding, and any future commercial relationship between Focus and C4V will remain subject to successful completion of the Program, definitive agreements and applicable corporate and regulatory approvals.

Qualified Person

The technical content disclosed in this news release was reviewed and approved by Richard Pearce, PE, President of Brasil Insight Capital LLC., a consultant to the Company, and a qualified person as defined under National Instrument NI 43-101.

About Charge CCCV LLC

Charge CCCV LLC, commonly known as C4V, is a U.S.-based lithium-ion battery technology company focused on battery-materials innovation, cell design, supply-chain qualification and advanced battery-manufacturing ecosystems. C4V’s platforms include battery-material evaluation, Digital DNA qualification, and technology pathways designed to support cleaner and more secure battery supply chains.

For more information on C4V, please visit https://www.chargecccv.com.

About Focus Graphite Inc.

Focus Graphite is building an integrated graphite platform to supply the industries shaping the future. Through the development of world-class graphite resources, advanced processing technologies and higher-value advanced materials, the Company is positioning itself to support battery, defence, advanced manufacturing and other strategic industries across North America and allied markets.

The platform is anchored by the Company’s two 100%-owned graphite assets in Quebec. Lac Knife is one of North America’s highest-grade feasibility-stage graphite deposits, while Lac Tetepisca is one of the largest identified graphite resources globally. Together with strategic technology partnerships and government-supported innovation initiatives, these assets provide the foundation for a secure, scalable and increasingly integrated graphite supply chain.

For more information on Focus Graphite Inc., please visit http://www.focusgraphite.com.

LinkedIn: https://www.linkedin.com/company/focus-graphite/
Facebook: https://www.facebook.com/focusgraphite
X: https://x.com/focusgraphite

Investors Contact:
Dean Hanisch
CEO, Focus Graphite Inc.
dhanisch@focusgraphite.com
+1 (613) 612-6060

Jason Latkowcer
VP Corporate Development
jlatkowcer@focusgraphite.com

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could,” “intend,” “expect,” “believe,” “will,” “projected,” “estimated,” and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company’s current beliefs or assumptions as to the outcome and timing of such future events.

In particular, this press release contains forward-looking information regarding, among other things, the proposed evaluation program contemplated under the non-binding Memorandum of Understanding between Focus Graphite Inc. and Charge CCCV LLC (“C4V”); the evaluation of Lac Knife graphite concentrate within C4V’s Green Anode Technology platform and related downstream processing and battery validation activities; the anticipated scope, results and potential benefits of the proposed evaluation program; the potential production and evaluation of coated spherical purified graphite (“cSPG”) and other higher-value graphite products; the suitability of Lac Knife graphite for processing through C4V’s Green Anode Technology and the achievement of anticipated technical, performance or commercial outcomes from the Program; the potential benefits associated with utilizing high-purity Lac Knife graphite concentrate as feedstock for downstream anode processing, including potential reductions in processing requirements, reagent and energy consumption, processing time and manufacturing costs, and potential improvements in manufacturing efficiency and product consistency; the potential evaluation and utilization of graphite fines and other processing streams as conductive additives or in other battery applications; the Company’s strategy to expand beyond graphite resource development into downstream processing and advanced materials; the advancement of the Company’s electrothermal graphite purification and other downstream processing initiatives; the potential development of an integrated North American mine-to-anode and battery materials supply chain; the future development and advancement of the Lac Knife Graphite Project; the potential for the Program to support future customer qualification, technology licensing, commercialization, downstream manufacturing, strategic partnerships, supply agreements, offtake arrangements or other commercial relationships with C4V or third parties; and the timing, scope and results of future technical programs, commercial discussions and definitive agreements.

Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company’s public disclosure documents available under its profile on SEDAR+.

The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.

Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.

¹ https://focusgraphite.com/focus-graphite-files-lac-knife-graphite-project-feasibility-study-technical-report/

² https://focusgraphite.com/focus-graphite-achieves-up-to-98-7-carbon-concentrate-through-mechanical-processing-and-activates-downstream-qualification-platform/

The issuer is solely responsible for the content of this announcement.

HONG KONG SAR – Media OutReach Newswire – 26 August 2026 – Redress, the Asia-focused environmental NGO dedicated to reducing clothing’s negative environmental impacts since 2007, is calling on consumers worldwide to vote online for their favourite Finalist in the Redress Design Award 2026, the world’s leading sustainable fashion design competition. Voting for the People’s Choice Award is open until 31 August 2026, with the winner to be announced at the Grand Final Fashion Show in Hong Kong on 2 September.

The Finalists’ collections showcase innovative approaches to tackling textile waste, transforming discarded leather offcuts, secondhand hardware and industrial waste through reconstruction and upcycling techniques, while exploring next-generation materials such as biodegradable fruit leather and ethical non-livestock wool to reimagine raw materials for circular fashion.

Organised by Redress and supported by the Cultural and Creative Industries Development Agency (CCIDA) of the Government of the Hong Kong Special Administrative Region as Lead Sponsor, the Redress Design Award invites the public to discover the tactile beauty of circular fashion through its latest photoshoot and cast their votes to champion sustainable fashion while empowering the next generation of circular design talents.

The photoshoot: sensory storytelling

Photographed by acclaimed Hong Kong creative Paul Sunga with hair by Davines and makeup by MakeupBees, the photoshoot celebrates the creative decisions behind each Finalist’s collection, highlighting the unique textures, craftsmanship and natural imperfections of their materials while underscoring why design matters: 80% of a garment’s environmental impact is determined at the design stage^[1].

“The Finalists of the Redress Design Award are proving that thoughtful design can transform textile waste into something beautiful. Getting up close to these garments, you see how every material choice, texture and technique tells a story, reminding us that the biggest opportunity to reduce fashion’s environmental impact begins at the design stage. I can’t wait for people to discover these collections through the photoshoot and vote for their favourite,” says photoshoot photographer Paul Sunga.

The Finalists’ collections are transported from overseas to Hong Kong for the photoshoot and upcoming Grand Final using DHL Express’ GoGreen Plus service. This service helps reduce greenhouse gas emissions through a Book & Claim mechanism, where the environmental attributes of Sustainable Aviation Fuel (SAF) are allocated to participating shipments. Made from alternative raw materials with a lower-emission energy profile, such as used cooking oil, waste and hydrogen, SAF can reduce the air transport shipments’ lifecycle greenhouse gas emissions by around 80 percent compared with conventional jet fuel.

Find out who wins at the grand final show

The People’s Choice Award winner will be announced at the Redress Design Award 2026 Grand Final Fashion Show, along with the coveted first prize including a week-long trip to the UK to connect with leading voices in sustainable fashion through a visit to Simple Approach’s Manchester operations to gain insight into responsible fashion design, development, and manufacturing, and an intensive experience with the team at luxury womenswear brand Roksanda to work on an upcycling design project.

The Redress Design Award 2026 Grand Final Fashion Show is open to an exclusive in-person audience and will be livestreamed globally on 2 September 2026 (Wednesday), at 5pm HKT / 11am CET via Facebook and WeChat. Save the date here.

Alumni showcase at centrestage open to public

Redress will also present a total of six Redress Alumni brands as part of both the Grand Final Fashion Show, and at a showcase of Alumni brands at CENTRESTAGE in Hong Kong from 2–5 September 2026 (Wednesday–Saturday, 11am–7pm) supported by DHL. Industry professionals and the public alike are all welcome to come, meet designers, and see up close their sustainable, waste-reducing collections.

The Redress Design Award 2026 Photoshoot Credits

• Photographer: Paul Sunga
• Models: Pak Yan Wong (Self Management Hong Kong), Max Holmström (Primo Management Ltd)
• Creative Stylist: Matthieu Amelin
• Hair: Henry Tse for Davines
• Make-up: Cindy Lai for MakeupBees
• Production: Katt Bidegain, Charly Cheung, Nancy Liu
• Studio: Soho House Hong Kong
• Lighting: Ming Suet
• BTS videographer: Jimmy Yu
• BTS photographer: Nicky Chan

Hashtag: #Redress

The issuer is solely responsible for the content of this announcement.

Redress

Redress (www.redress.com.hk) is a Hong Kong-based, Asia-focused environmental NGO with a mission to accelerate the change to a circular fashion industry by educating and empowering designers and consumers so as to reduce clothing’s negative environmental impacts.

The Redress Design Award

The Redress Design Award (www.redressdesignaward.com) is the world’s leading sustainable fashion design competition that educates and empowers emerging fashion designers about circular design techniques to reduce fashion’s negative environmental impacts. Organised by Hong Kong-based, Asia-focused environmental NGO Redress since 2011, the competition partners with academic institutions globally and attracts designer applicants from over 50 countries and regions to win prizes that connect them with global-leading fashion businesses to accelerate the change to a circular fashion industry.

Cultural and Creative Industries Development Agency (CCIDA)

The Cultural and Creative Industries Development Agency (CCIDA) (www.ccida.gov.hk), formerly known as Create Hong Kong (CreateHK) since 2009, was established in June 2024. CCIDA is a dedicated office under the Culture, Sports and Tourism Bureau of the Government of the Hong Kong Special Administrative Region (HKSAR Government) to provide one-stop services and support to the cultural and creative sectors with a mission to foster a conducive environment in Hong Kong to facilitate development of the arts, culture and creative sectors as industries. CCIDA’s strategic foci are nurturing talent and facilitating start-ups, exploring markets, promoting cross-sectoral and multi-disciplinary collaboration, promoting industrialisation of the arts, culture and creative sectors under the industry-oriented principle, and fostering a creative atmosphere in the community, thereby reinforcing Hong Kong as Asia’s creative capital and our positioning as the East-meets-West centre for international cultural exchange.

Disclaimer: The Government of the Hong Kong Special Administrative Region provides funding support to the project only, and does not otherwise take part in the project. Any opinions, findings, conclusions or recommendations expressed in these materials/events (or by members of the project team) are those of the project organisers only and do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Culture, Sports and Tourism Bureau, the Cultural and Creative Industries Development Agency, the CreateSmart Initiative Secretariat or the CreateSmart Initiative Vetting Committee.

LJUBLJANA, SLOVENIA – Media OutReach Newswire – 22 August 2026 – On August 20, 2026, Ljubljana, the capital of Slovenia, shone even brighter as it celebrated its renowned music festival. The youthful Wuxi Symphony Orchestra, hailing from Wuxi, China’s first UNESCO “City of Music,” stepped into the heartland of classical music for the very first time under the leadership of Artistic Director and Chief Conductor Lin Daye. Inside a packed Gallus Hall at Cankarjev Dom, a profound and heartfelt musical dialogue unfolded between East and West.

As Slovenia’s largest international summer music festival, its stage saw the name of Wuxi, China, etched upon it for the very first time this summer. As the conductor’s baton cut through the silence, this ancient Central European city warmly welcomed the debut of this Eastern orchestra with thunderous, prolonged applause.

The concert opened to the magnificent sounds of the Overture to Verdi’s I vespri siciliani, with Lin Daye delivering the passion of Italian opera through his deeply expressive conducting. The orchestra then presented the festival debut of Fly To The Sky, an original symphonic suite by Li Shaosheng, whose embedded Eastern worldview resonated profoundly with the audience. Suona virtuoso Zhang Qianyuan’s performance in Questioning the Heavens was high-pitched and evocative, while tenor Xue Haoyin sang with heroic majesty in Heaven’s Movement is Strength, driving the atmosphere to a climax.

In the second half, the orchestra performed Brahms’ Symphony No. 1 in C minor. On a stage that has witnessed countless iconic performances of German-Austrian classics, the orchestra paid tribute to heritage through a precise yet impassioned interpretation. As the grand theme of the finale—symbolizing “through darkness into light”—echoed through the hall, the entire audience rose to their feet in a standing ovation, expressing high acclaim for the orchestra’s flawless execution. Darko Brlek, Artistic Director of the Ljubljana Festival, noted that this was the very first standing ovation given to a Chinese orchestra in the festival’s history of over 70 editions.

As the opening stop of their 2026 European tour, the Ljubljana performance marked a striking debut and strong statement of cultural confidence. Showcasing Jiangnan’s Wuxi to the world, these musical ambassadors from Lake Taihu foster cross‑cultural understanding through music, letting the world hear and understand China.

Click the link to watch the Wuxi Symphony Orchestra’s performance in Slovenia: https://youtu.be/Ghk3aIYcHXc?si=PzVdV99ZikOqiMA7

Hashtag: #WuxiSymphonyOrchestra

The issuer is solely responsible for the content of this announcement.

BANGKOK, THAILAND – Media OutReach Newswire – 26 August 2026 – Thailand’s electronics sector has secured over $30.5 billion (1 trillion baht) in investment since 2023. Roughly a third of this capital—exceeding $10.1 billion (331 billion baht) across 224 projects—is concentrated in printed circuit boards (PCBs) and electronic components, driven by global manufacturers scaling their footprint in AI hardware and advanced semiconductor packaging across Southeast Asia.

The investment momentum takes center stage at the Thailand Electronics Circuit Asia (THECA 2026) summit at Bangkok’s BITEC exhibition center, which convenes more than 300 global tech enterprises and 7,000 international delegates across 40 nations. The summit’s program includes more than 60 conference sessions spanning AI infrastructure, the semiconductor ecosystem, photonics, advanced packaging, PCBs, and electronics manufacturing services. The event reinforces the accelerating realignment of critical electronics manufacturing toward Southeast Asia amid ongoing global supply chain diversification.

The technological drive comes as Thai policymakers accelerate structural reforms aimed at overcoming the middle-income trap, lifting the country’s global competitiveness ranking into the world’s top 20, and driving annual gross domestic product growth.

With the electronics sector serving as a primary economic engine, the Thailand Board of Investment (BOI) is shifting its focus from basic capital attraction to maximizing national competitiveness. The agency’s four-pillar framework prioritizes high-value and high-potential sectors, enhances Thailand’s readiness for leading multinationals, deepens local economic benefits by upskilling the workforce and fortifying domestic supply chains, and builds international cooperation to connect Thai firms to global production networks.

“The investments flowing into Thailand’s electronics sector today are fundamentally different from those of three decades ago,” said Mr. Narit Therdsteerasukdi, Secretary General of the Thailand Board of Investment (BOI). “They are driven by frontier technologies, proprietary knowledge, and highly skilled labor. Our objective is not merely keeping pace with global technology, but anchoring Thailand as an indispensable co-creator of the future global supply chain.”

Thailand’s selection to host the 17th Electronic Circuits World Convention (ECWC17) in August 2027 — a triennial flagship event that rotates among the world’s premier electronics manufacturing economies — further underscores the country’s rising clout in global electronics manufacturing.
Industry leaders note that surging demand for edge computing, smart mobility, and artificial intelligence is reshaping regional manufacturing footprints.

“In an era dominated by rapid breakthroughs in AI, advanced packaging, and semiconductors, competitive advantage is no longer determined by brute manufacturing capacity alone,” said Mr. Canice Chung, Chairman of the Hong Kong Printed Circuit Association (HKPCA), a co-organizer of the event. “It hinges on international knowledge transfer, cross-border research cooperation, and developing specialized technical talent.”

To strengthen regional collaboration, the summit introduces dedicated platforms such as Power2Motion, focusing on power electronics and future mobility systems, alongside the ASEAN+ Technology Pavilion, which unites 15 robotics, AI, and IoT industry alliances from Thailand, Malaysia, Singapore, and Vietnam.

“Thailand is building the critical mass necessary to serve as Asia’s next-generation electronics nexus,” noted Mr. Pithan Ongkosit, President of the Thai Printed Circuit Association (THPCA), as THECA holds its third consecutive edition. “Uniting every tier of the supply chain — from raw substrates and automated machinery to semiconductors and advanced packaging — creates essential commercial scale and accelerates technology adoption across the region.”

As regional competition for high-tech capital intensifies, Thai investment officials are emphasizing the co-development of domestic capabilities alongside foreign investment.

“By synchronizing foreign direct investment with our domestic manufacturers, academic institutions, and next-generation engineering talent, we are cementing Thailand’s position as the regional hub for smart electronics manufacturing — creating high-value jobs and driving sustainable economic growth,” Mr. Narit said.

Note: Currency conversions are based on the Bank of Thailand’s average selling rate of approximately 1 USD = 32.8 THB.

Hashtag: #Thailandboardofinvestment #BOI #FDI #Investment #AI #technology

https://www.boi.go.th/en/index/

The issuer is solely responsible for the content of this announcement.

Thailand Board of Investment (BOI)

Established in 1966, the Office of the Board of Investment (BOI) has continuously played an essential role for over 60 years in promoting value-adding investment for the country, from both foreign and Thai investors, to enhance national competitiveness and drive toward a new era of sustainable and balanced growth.

Investment Services Center- PR Section, The Office of the Board of Investment (BOI)

555 Vibhavadi-Rangsit Road, Chatuchak, Bangkok 10900 Tel. +66 (0) 2553 8111, Fax: +66 (0) 2553 8222

SINGAPORE – Media OutReach Newswire – 26 August 2026 – On Sunday, 26 July 2026, Dr. Terence Tan of Halley Body Slimming Clinic presented at the Society of Aesthetic Medicine (Singapore) Conference 2026. Organised by the Society of Aesthetic Medicine (Singapore), the two-day conference brought together doctors to discuss developments across aesthetic medicine and related areas of clinical practice. In his presentation, “Achieving More With Semaglutide: The STEP UP Evidence”, Dr. Tan reviewed recent clinical evidence on semaglutide treatments while also examining a wider question: how should doctors support patients before, during, and after medical weight loss?

Looking beyond semaglutide treatment in isolation

Semaglutide belongs to a class of medicines known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. Dr. Tan began by reviewing how these GLP-1 injectables work and the growing body of research investigating their role in weight management.

A central part of the presentation focused on the Semaglutide Treatment Effect in People with obesity (STEP) clinical development programme and, in particular, the STEP UP trial. STEP UP was a 72-week randomised, double-blind, multicentre, placebo-controlled trial involving adults with obesity and without type 2 diabetes. Participants received once-weekly semaglutide 7.2 mg, semaglutide 2.4 mg, or placebo, alongside a lifestyle intervention that included dietary modification and physical activity.

Under the treatment-policy analysis, mean body-weight change at week 72 was -18.7% among participants receiving semaglutide 7.2 mg, compared with -15.6% with semaglutide 2.4 mg and -3.9% with placebo. The study also examined the proportions of participants achieving higher levels of body-weight reduction.

However, the presentation did not position higher weight-loss percentages as the sole goal of treatment. Instead, Dr. Tan used the evidence as a starting point for discussing how weight management plans may need to evolve as medical treatments make more substantial weight reduction possible.

Navigating patient selection for semaglutide treatment

After reviewing the STEP evidence, Dr. Tan turned to how these findings translate into clinical decision-making, starting with one of the most important questions in practice: who is suitable for semaglutide treatment, and at what dose?

During the presentation, Dr. Tan shared that semaglutide is indicated as an adjunct to a reduced-calorie diet and increased physical activity for adults with an initial BMI of:

• 30 kg/m² or above, which falls within the obesity range; or
• 27 kg/m² to below 30 kg/m², where at least one weight-related comorbidity is present.

However, these numerical thresholds are only one part of the assessment. In everyday GP and aesthetic practice, doctors may encounter patients with very different motivations, health profiles, and circumstances. Dr. Tan’s presentation therefore raised broader considerations such as Asian ethnicity, psychological and social factors, occupational pressures, and the resources available within the clinic to provide appropriate ongoing care.

This reinforces the need to assess the individual patient rather than viewing semaglutide as a treatment based on weight or BMI alone.

Weight management remains a clinical process

Additionally, Dr. Tan emphasised that prescription weight loss medication represents only one part of weight management. Semaglutide treatment can be used to support weight reduction in suitable patients, but doctors should take into account the patient’s goals, lifestyle changes, commitment to treatment, and support system.

To address this, he highlighted several areas that should be addressed alongside medication:

• Treatment goals: His presentation discussed establishing realistic weight goals from the outset and reviewing progress over time, rather than focusing only on the number shown on the weighing scale at each visit.
• Lifestyle changes: Diet and exercise remained central to his approach. Rather than prescribing one way of eating, he encouraged doctors to consider different dietary approaches and support sustainable lifestyle changes.
• Motivation and support: Dr. Tan stressed the importance of “treating the mind as well as the body” by helping patients commit to the process and, where appropriate, involving family and friends. This recognises that longer-term weight management also depends on motivation, behaviour, and the patient’s support system.
• Ongoing follow-up: He suggested beginning with monthly reviews, checking for nausea and other side effects, reinforcing positive lifestyle changes, and adjusting the interval between visits according to the patient’s clinical needs.
• Wider care and community support: The presentation also pointed to the possible role of healthcare clusters, nurse practitioners, medical social workers, and other support networks where appropriate.

Taken together, these points positioned semaglutide treatment as one component within a longer-term management process rather than a standalone solution. The doctor’s role, in Dr. Tan’s framework, extends from deciding who may be suitable for treatment to helping patients navigate lifestyle changes, treatment tolerability, ongoing motivation, and the support they may need along the way.

Taking a broader approach to weight management and aesthetics

Towards the end of his presentation, Dr. Tan also explored how weight management can intersect with aesthetic care in two different ways.

First, weight loss itself can affect skin laxity. As a patient loses a significant amount of weight, the reduction in underlying fat volume may leave the skin looking looser, particularly where there has been a substantial change in body size. This means that skin laxity may become a separate aesthetic concern that needs to be assessed after, or during, the weight management journey.

Second, there is the question of treatment sequencing. Dr. Tan raised whether weight management should always come before aesthetic treatments such as CoolSculpting Elite body contouring. While he noted that body contouring does not contribute to overall weight loss, he emphasised that treatment planning should not follow a rigid sequence for every patient. Instead, doctors should take into account the patient’s individual concerns, circumstances, and preferences. Weight management, fat reduction, and skin-tightening treatments address different needs and may therefore be considered at different stages of a patient’s care.

From clinical evidence to patient care

Dr. Tan’s presentation brought the discussion back to a practical point: semaglutide is only one part of a patient’s broader weight management journey. The way doctors plan and navigate treatment should change over time, particularly as their patients’ health priorities, weight-related concerns, and aesthetic considerations evolve.

This patient-led approach also underpins Dr. Tan’s work at Halley Body Slimming Clinic, where weight management is considered in the context of each patient’s wider needs rather than as a standalone treatment. Patients can visit their website to learn more about the clinic’s treatment philosophy and the range of weight management and body-contouring services available.

Hashtag: #halleybodyslimming #weightlossinjection #weightlosssingapore #medicalweightmanagement

The issuer is solely responsible for the content of this announcement.

About Halley Body Slimming Clinic

Halley Body Slimming Clinic is a clinic in Singapore that offers doctor-led weight management, body contouring, and skin tightening treatments. Patients undergo a clinical assessment before a treatment plan is recommended based on their individual concerns, goals, and suitability. Services include prescription weight-loss medication, as well as non-invasive fat-reduction and body-contouring treatments such as CoolSculpting Elite and Vanquish. The clinic also emphasises regular follow-up and patient education, allowing treatment plans to be reviewed as patients progress toward their weight management goals.